Craig Johnstone - Evotec SE COO Board
| EVO Stock | USD 5.17 0.08 1.57% |
Insider
Craig Johnstone is COO Board of Evotec SE ADR
| Age | 54 |
| Address | Essener Bogen 7, Hamburg, Germany, 22419 |
| Phone | 49 40 560 81 0 |
| Web | https://www.evotec.com |
Evotec SE Management Efficiency
As of the 22nd of May 2024, Return On Tangible Assets is likely to drop to -0.04. In addition to that, Return On Capital Employed is likely to drop to -0.06. At this time, Evotec SE's Intangibles To Total Assets are very stable compared to the past year. As of the 22nd of May 2024, Debt To Assets is likely to grow to 0.29, while Other Assets are likely to drop 1.09. Evotec SE's management efficiency ratios could be used to measure how well Evotec SE manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jonathan Rubin | Supernus Pharmaceuticals | 63 | |
| Adel Mekhail | Prestige Brand Holdings | 63 | |
| Thomas JD | Deciphera Pharmaceuticals LLC | 53 | |
| Dean Siegal | Prestige Brand Holdings | N/A | |
| Marlo Manning | Collegium Pharmaceutical | N/A | |
| Mukesh Rathi | Dr Reddys Laboratories | 45 | |
| Jean Filippi | Phibro Animal Health | N/A | |
| Brian Cahill | Eagle Pharmaceuticals | 55 | |
| Daniel OConnor | Eagle Pharmaceuticals | 44 | |
| Deepak MBA | Dr Reddys Laboratories | 49 | |
| K Singh | Dr Reddys Laboratories | N/A | |
| Gregory Gentile | Silver Spike Investment | 48 | |
| MS BTech | Dr Reddys Laboratories | 57 | |
| Jude Onyia | Neurocrine Biosciences | 59 | |
| Scott Gordon | Silver Spike Investment | 63 | |
| Penny Wan | Dr Reddys Laboratories | N/A | |
| Scott Sudduth | Collegium Pharmaceutical | N/A | |
| Jama Pitman | Deciphera Pharmaceuticals LLC | 44 | |
| Philip Terpolilli | Prestige Brand Holdings | N/A | |
| Eiry MD | Neurocrine Biosciences | 59 | |
| Erez MBA | Dr Reddys Laboratories | 56 | |
Management Performance
| Return On Equity | -0.0727 | ||||
| Return On Asset | 3.0E-4 |
Evotec SE ADR Leadership Team
Elected by the shareholders, the Evotec SE's board of directors comprises two types of representatives: Evotec SE inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Evotec. The board's role is to monitor Evotec SE's management team and ensure that shareholders' interests are well served. Evotec SE's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Evotec SE's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Matthias Evers, Chief Board | ||
| Mario DPHIL, Member CEO | ||
| Monika Conradt, Global Resources | ||
| MBA MPA, Member Board | ||
| Christian Dargel, EVP Compliance | ||
| Anja Bosler, Principal Accounting | ||
| Volker Braun, Executive ESG | ||
| Cord Dohrmann, Chief Board | ||
| Enno Spillner, CFO Board | ||
| MBA MBA, Chairman CEO | ||
| Gabriele Hansen, Senior Marketing | ||
| Craig Johnstone, COO Board | ||
| Laetitia Rouxel, CFO Board |
Evotec Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Evotec SE a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0727 | ||||
| Return On Asset | 3.0E-4 | ||||
| Profit Margin | (0.11) % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 922.69 M | ||||
| Shares Outstanding | 354.37 M | ||||
| Shares Owned By Institutions | 1.40 % | ||||
| Number Of Shares Shorted | 169.52 K | ||||
| Price To Earning | 444.00 X | ||||
| Price To Book | 2.12 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Evotec Stock analysis
When running Evotec SE's price analysis, check to measure Evotec SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evotec SE is operating at the current time. Most of Evotec SE's value examination focuses on studying past and present price action to predict the probability of Evotec SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evotec SE's price. Additionally, you may evaluate how the addition of Evotec SE to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Evotec SE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evotec SE. If investors know Evotec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evotec SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.26) | Revenue Per Share 2.2085 | Quarterly Revenue Growth (0.16) | Return On Assets 0.0003 | Return On Equity (0.07) |
The market value of Evotec SE ADR is measured differently than its book value, which is the value of Evotec that is recorded on the company's balance sheet. Investors also form their own opinion of Evotec SE's value that differs from its market value or its book value, called intrinsic value, which is Evotec SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evotec SE's market value can be influenced by many factors that don't directly affect Evotec SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evotec SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evotec SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evotec SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.